Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about SNY

Recent news which mentions SNY

< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
FDA Panel Rejects Lexicon's Zynquista For Type 1 Diabetes
Tickers LXRX NEWS SHL SNY
Tags News SNY SHL
From Benzinga
Why Is Regeneron Pharmaceuticals Stock Trading Lower Today?
Tickers NEWS NVO REGN SNY
Tags Briefs REGN Movers
From Benzinga
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split
Tickers AMGN CMG GS LLY
Tags REGN SNY ROG
From Motley Fool
Why Sanofi Stock Flew Higher on Friday
Tickers SNY
Tags Market News Recent Press Releases SNY
From Motley Fool
Sanofi (SNY) Q3 2024 Earnings Call Transcript
Tickers SNY
Tags Recent Press Releases Market News SNY
From Motley Fool
Eli Lilly's Newly FDA-Approved Eczema Drug Improves Skin And Itch In Patients Previously Treated With Sanofi/Regeneron's Dupixent
Tickers LLY NEWS REGN SNY
Tags Health Care LLY News
From Benzinga
Sanofi Earns $5B Q3 Core Profit On Strong Dupixent And Vaccine Sales, Raises 2024 Forecast
Tickers AZN NEWS SNY
Tags Large Cap Guidance News
From Benzinga
Sanofi's Earnings Outlook
Tickers SNY
Tags SNY BZI/EP Market News
From Benzinga
Sanofi Engages In Exclusive Talks With US Private Equity CD&R For Its Consumer Health Business
Tickers NEWS SNY
Tags Health Care News Large Cap
From Benzinga
This Vaccine Stock Just Dropped by 20%: Should You Buy the Dip?
Tickers NVAX SNY
Tags SNY Market News Recent Press Releases
From Motley Fool
European Medicines Agency's Panel Supports Approval Of Novartis' Kisqali In Patients With Early-Breast Cancer
Tickers NEWS NVS SNY
Tags Large Cap News SNY
From Benzinga
France's PAI Partners Ups Bid for Sanofi's Consumer Health Division As French Government Hints Possible Regulatory Block
Tickers NEWS SNY
Tags General Biotech Benzinga
From Benzinga
Sanofi Might Face Political Hurdles In $16B Consumer Pharma Unit Sale To US Private Equity CD&R
Tickers NEWS SNY
Tags General Media Stories That Matter
From Benzinga
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice
Tickers BX GS GSK HLN
Tags Briefs MS Biotech
From Benzinga
Denali Therapeutics Stock Is Sliding After The Bell: Here's Why
Tickers DNLI NEWS SNY
Tags Market News Danielle Brill why it's moving
From Benzinga
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Tickers ABBV CSLLY GILD GSK
Tags Price Target Expert Ideas dividend yield
From Benzinga
2 Artificial Intelligence Stocks That Could Deliver Explosive Gains
Tickers RHHBY RXRX SNY SOUN
Tags Recent Press Releases RXRX SNY
From Motley Fool
GSK, Sanofi, And CSL Secure US Government Fund To Boost Bird Flu Vaccine Production: Report
Tickers CSLLY GSK NEWS SNY
Tags Financing General Benzinga
From Benzinga
Sanofi Sells Global Rights To Rare Autoimmume Drug Enjaymo For $825M Upfront To Italian Firm Recordati
Tickers NEWS SNY
Tags Stories That Matter Benzinga Biotech
From Benzinga
Novo Nordisk/AstraZeneca's Manufacturing Partner Thermo Fisher Questioned Over Manufacturing Lapses
Tickers AZN MRK NEWS NVO
Tags Market News TMO AZN
From Benzinga
US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could be Next
Tickers AZN LLY NEWS NVO
Tags Government Briefs PFE
From Benzinga
FDA Approves Regeneron/Sanofi's Blockbuster Dupixent For Smoker's Lung Disease
Tickers NEWS REGN SNY
Tags why it's moving Market News SNY
From Benzinga
Amgen's Rocatinlimab Has Commercial Potential Despite Competitive Landscape, Says Goldman Sachs
Tickers AMGN LLY NEWS SNY
Tags Market News Analyst Color Analyst Ratings
From Benzinga
Amgen's Rocatinlimab Data Beats Placebo In Atopic Dermatitis Trial, But Analyst Says Data Raises Concerns Amid Competitive Market
Tickers AMGN CGEM NEWS REGN
Tags General Biotech CGEM
From Benzinga
Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff
Tickers GS GSK HLN JNJ
Tags SNY News Large Cap
From Benzinga
Sanofi Injects $27M In Neurology Drug Developer Ventyx Biosciences
Tickers NEWS SNY VTYX
Tags General Parkinson's Financing
From Benzinga
Sanofi's Sarclisa Secures FDA Approval For First-Line Multiple Myeloma, Marking Its Third US Approval
Tickers NEWS SNY
Tags FDA General Biotech
From Benzinga
US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
Tickers CI CVS LLY NEWS
Tags General Legal UNH
From Benzinga
Sanofi's Tolebrutinib Delays Disability Progression In Patients With Multiple Sclerosis, Data Shows
Tickers NEWS SNY
Tags Market News SNY Large Cap
From Benzinga
Novartis' Multiple Sclerosis Drug Data Shows Most Patients Remain With No Disability Progression For Up To Six Years
Tickers NEWS NVS SNY
Tags Biotech Benzinga Health Care
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.